Hsu CR, Chen JT, Yeh KM, et al. A cluster of nontuberculous mycobacterial endophthalmitis (NTME) cases after cataract surgery: Clinical features and treatment outcomes. Eye (Lond), 2018, 32(9): 1504-1511. DOI: 10.1038/s41433-018-0108-1.
[2]
Steinbrink J, Leavens J, Kauffman CA, et al. Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients. Medicine (Baltimore), 2018, 97(40): e12436. DOI: 10.1097/MD.0000000000012436.
[3]
Dutta Majumder P, Mukherjee M, Therese L, et al. Diagnostic challenge with nocardia subretinal abscess: A case report from tuberculosis-endemic region. Ocul Immunol Inflamm, 2019, 27(5): 762-765. DOI: 10.1080/09273948.2018.1462391.
[4]
Silva RA, Young R, Sridhar J, et al. Nocardia choroidal abscess: Risk factors, treatment strategies, and visual outcomes. Retina, 2015, 35 (10): 2137-2146. DOI: 10.1097/IAE.0000000000000599.
[5]
Hamdi AM, Fida M, Deml SM, et al. Retrospective analysis of antimicrobial susceptibility profiles of nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017. Antimicrob Agents Chemother, 2020, 64(3): e01868-19. DOI: 10.1128/AAC.01868-19.
Valdezate S, Garrido N, Carrasco G, et al. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain. J Antimicrob Chemother, 2017, 72(3): 754- 761. DOI: 10.1093/jac/dkw489.
Chen LY, Kesen MR, Ghafourian A, et al. Isolated endogenous Nocardia endophthalmitis after immunosuppression. J Ophthalmic Inflamm Infect, 2012, 2(3): 141-143. DOI: 10.1007/ s12348-011-0057-3.
[12]
Eschle-Meniconi ME, Guex-Crosier Y, Wolfensberger TJ. Endogenous ocular nocardiosis: an interventional case report with a review of the literature. Surv Ophthalmol, 2011, 56(5): 383-415. DOI: 10.1016/j.survophthal.2011.03.003.
[13]
Milman T, Trubnik V, Shah M, et al. Isolated Nocardia exalbida endogenous endophthalmitis. Ocul Immunol Inflamm, 2011, 19(4): 237-239. DOI: 10.3109/09273948.2011.563898.